Yahoo Web Search

  1. Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see AbbVie Inc. (NYSE:ABBV) is about to trade ex-dividend in the next 3 days ...

  2. Were Hedge Funds Right About Snapping Up AbbVie Inc (ABBV)?

    Insider Monkey via Yahoo FinanceOct 08 21:54 PM

    AbbVie Inc (NYSE:ABBV) was in 55 hedge funds' portfolios at the end of the second quarter of 2019. ABBV has seen an increase in enthusiasm from smart money in recent months. There ...

  3. CTAS, Air Products and Chemicals, Inc. APD, Walmart Inc. WMT, Target Corp. TGT and AbbVie Inc. ABBV. Despite the U.S.-China trade concerns, impeachment jitters, uncertainty ...

  4. Allergan (AGN) Shareholders Approve Acquisition by AbbVie

    Zacks via Yahoo FinanceOct 15 21:04 PM

    Allergan plc AGN announced that its shareholders have approved its pending acquisition by AbbVie, Inc. ABBV. Allergan said that approximately 68.6% of shareholders eligible to ...

  5. This is Why AbbVie (ABBV) is a Great Dividend Stock

    Zacks via Yahoo FinanceOct 14 13:15 PM

    AbbVie (ABBV) is headquartered in North Chicago, and is in the Medical sector. Over the last 5 years, AbbVie has increased its dividend 5 times on a year-over-year basis for an ...

  6. AbbVie (ABBV) Stock Moves -0.44%: What You Should Know

    Zacks via Yahoo FinanceOct 07 21:45 PM

    Wall Street will be looking for positivity from ABBV as it approaches its next earnings report date. On that day, ABBV is projected to report earnings of $2.27 per share, which would represent ...

  7. NASDAQ: AEZS) Agios Pharmaceuticals Inc (NASDAQ: AGIO) Albireo Pharma Inc (NASDAQ: ALBO) Arbutus Biopharma Corp (NASDAQ: ABUS) Assembly Biosciences Inc (NASDAQ: ASMB) Aurinia ...

  8. AbbVie (ABBV) Gains As Market Dips: What You Should Know

    Zacks via Yahoo FinanceOct 14 21:45 PM

    AbbVie (ABBV) closed the most recent trading day at $73.76, moving +0.18% from the previous trading session. ABBV will be looking to display strength as it nears its next earnings release ...

  9. AbbVie Inc's rheumatoid arthritis drug Humira and Roche Holding AG's cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for ...

  10. AbbVie Inc's arthritis drug Humira and Roche Holding AG's cancer drug Rituxan top the list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $5.1 billion ...